Cargando…
Proteomic analysis of stage I primary lung adenocarcinoma aimed at individualization of postoperative therapy
Autores principales: | Maeda, J, Hirano, T, Ogiwara, A, Akimoto, S, Kawakami, T, Fukui, Y, Oka, T, Gong, Y, Guo, R, Inada, H, Nawa, K, Kojika, M, Suga, Y, Ohira, T, Mukai, K, Kato, H |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2441957/ http://dx.doi.org/10.1038/sj.bjc.6604414 |
Ejemplares similares
-
Proteomic analysis of stage I primary lung adenocarcinoma aimed at individualisation of postoperative therapy
por: Maeda, J, et al.
Publicado: (2008) -
MUTYH, an adenine DNA glycosylase, mediates p53 tumor suppression via PARP-dependent cell death
por: Oka, S, et al.
Publicado: (2015) -
Corrigendum to: Aiming at harmony. Comparing and contrasting International HFrEF Guidelines
Publicado: (2023) -
Uracil-tegafur and tamoxifen versus cyclophosphamide, methotrexate, fluorouracil, and tamoxifen in postoperative adjuvant therapy for stage I, II, or IIIA lymph node-positive breast cancer: a comparative study
por: Park, Y, et al.
Publicado: (2009) -
The challenge of increasing Pfam coverage of the human proteome
por: Mistry, Jaina, et al.
Publicado: (2013)